Nyxoah S.A. (NYXH) Revenue History
Annual and quarterly revenue from 2017 to present
NYXH Revenue Over Time (2017–2025)
NYXH Revenue Growth History
5 of 5 years with positive growth- FY2017 revenue growth
- N/A
- FY2018 revenue growth
- N/A
- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- +1134.8%
- FY2022 revenue growth
- +262.0%
- FY2023 revenue growth
- +41.0%
- FY2024 revenue growth
- +4.0%
- FY2025 revenue growth
- +121.6%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $7.4M | +591.9% |
| Q4 2025 | $5.6M | +346.9% |
| Q3 2025 | $2.0M | +55.8% |
| Q2 2025 | $1.3M | +73.8% |
| Q1 2025 | $1.1M | -12.9% |
| Q4 2024 | $1.3M | -30.8% |
| Q3 2024 | $1.3M | +29.7% |
| Q2 2024 | $771K | -30.4% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown
NYXH's revenue distribution by segment and geography
By Geography
NYXH Revenue Analysis (2017–2025)
Current Revenue & Growth
As of June 13, 2026, Nyxoah S.A. (NYXH) generated trailing twelve-month (TTM) revenue of $16.3 million, reflecting explosive growth of +591.9% year-over-year. The most recent quarter (Q1 2026) recorded $7.4 million in revenue, up 30.4% sequentially.
Historical Growth Trajectory
NYXH's 5-year compound annual growth rate (CAGR) stands at +170.6%, indicating outstanding long-term growth trajectory. The 3-year CAGR of +48.1% is below the 5-year average, signalling a growth deceleration in recent years. Nyxoah S.A.'s highest annual revenue of $10.0 million was recorded in 2025, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including INSP (+8.9% YoY), LIVN (+12.4% YoY), and AVAV (+116.9% YoY) — NYXH has outperformed the peer group in revenue growth. Compare NYXH vs INSP →
NYXH Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
 NYXHCurrent | $16M | +591.9% | +170.6% | -827.8% | |
 INSP | $912M | +8.9% | +51.2% | 5.6% | |
 LIVN | $1.4B | +12.4% | +8.2% | 14.4% | |
 AVAV | $821M | +116.9% | +17.4% | 5.0% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ELMD | $64M | +16.8% | +14.5% | 15.4% |
NYXH Historical Revenue Data (2017–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $10.0M | +121.6% | $6.3M | 63.1% | $-82,942,000 | -827.8% |
| 2024 | $4.5M | +4.0% | $3.0M | 65.7% | $-58,809,000 | -1300.8% |
| 2023 | $4.3M | +41.0% | $2.7M | 61.9% | $-45,102,000 | -1037.3% |
| 2022 | $3.1M | +262.0% | $1.9M | 62.7% | $-32,499,000 | -1053.8% |
| 2021 | $852K | +1134.8% | $549K | 64.4% | $-26,242,000 | -3080.0% |
| 2020 | $69K | - | $39K | 56.5% | $-11,224,000 | -16266.7% |
| 2019 | $0 | - | $-486,042 | - | $-8,518,648 | - |
| 2018 | $0 | - | $-2,523,000 | - | $-8,450,000 | - |
| 2017 | $0 | - | $-2,110,000 | - | $-10,143,000 | - |
What if you invested $1,000 in NYXH back in 2017?
Total return with dividends reinvested · 9+ years of data
Calculate ReturnsHow much would $100/month in NYXH be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs NYXH Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationNYXH vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowNYXH — Frequently Asked Questions
Quick answers to the most common questions about buying NYXH stock.
Is NYXH's revenue growth accelerating or slowing?
NYXH revenue growth is accelerating. TTM revenue reached $16M, up +591.9% year-over-year — ahead of the 5-year CAGR of +170.6%. This indicates the business is expanding faster than its historical baseline.
What is NYXH's revenue history from 2017 to 2026?
Nyxoah S.A. (NYXH) revenue history spans 2017 to 2026. TTM revenue as of 2026 is $16M, growing at +591.9% YoY. The 5-year CAGR is +170.6%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is NYXH's long-term revenue growth rate (CAGR)?
Nyxoah S.A.'s 5-year revenue CAGR of +170.6% reflects the sustained nature of its business expansion. As of 2026, the current YoY growth rate of +591.9% is above this long-term average. CAGR is the most reliable measure of sustained revenue momentum for NYXH.
Why does NYXH's quarterly revenue fluctuate?
NYXH quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Nyxoah S.A.'s revenue data from 2017 to 2026 shows full historical quarterly detail on this page.
How is NYXH's revenue distributed by segment?
NYXH reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does NYXH's revenue compare to industry peers?
Nyxoah S.A. (NYXH) with TTM revenue of $16M and +591.9% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.